Evidence map›Paper›PMID 42876837›Full record

ArticleFrontiers in immunology2026

Keratinocyte-derived CXCL-CXCR2 ligand-receptor axis by MED1 orchestrates neutrophil phenotypes during psoriasis.

Yingxi Li, Junkai Huang, Guixin Wang, Jing Luo, Zhikai Cao, Lin Li, Qi Guo, Qianshu Yuan, Mingwei Li, Ziyu Zhang and 3 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yingxi Li *Health Science Center, Ningbo University, Ningbo, Zhejiang, China.
Junkai Huang *Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China.
Guixin Wang *Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Jing LuoImmunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China.
Zhikai CaoHealth Science Center, Ningbo University, Ningbo, Zhejiang, China.
Lin LiDepartment of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
Qi GuoImmunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China.
Qianshu YuanImmunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China.
Mingwei LiImmunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China.
Ziyu ZhangImmunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China.
Weibin XingDepartment of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
Long SuDepartment of Ophthalmology, Second Hospital of Tianjin Medical University, Tianjin, China.
Lizhi HuImmunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Psoriasis is a chronic inflammatory skin disease characterized by aberrant keratinocyte proliferation and dysregulated immune responses. Increasing evidence suggests that reciprocal communication between tissue-resident keratinocytes and infiltrating immune cells shapes the inflammatory microenvironment and governs disease progression. However, the molecular mechanisms underlying this immune-parenchymal crosstalk remain incompletely understood. Methods: Here, we generate epidermal-specific Med1 conditional knockout (cKO) mice using the Cre-loxP system and induce psoriasis model with imiquimod (IMQ). To characterize immune-parenchymal interactions, single-cell RNA sequencing (scRNA-seq) was performed on lesional skin from cKO and wild-type (WT) mice. The underlying mechanisms governing keratinocyte-neutrophil communication were further investigated using flow cytometry, CellChat analysis, dual-luciferase reporter assays, transwell migration assays, and qRT-PCR. Results: Epidermal deficiency of Med1 markedly alleviated IMQ-induced psoriasis, as evidenced by reduced epidermal thickness and diminished inflammatory cytokine production. The scRNA-seq result showed epithelial cells were reduced, accompanied with the significantly diminished neutrophil accumulation in cKO mice. Flow cytometry analysis also showed that CD45 Conclusions: Collectively, our findings identify previously unrecognized neutrophil subtypes and demonstrates that epithelial Med1 regulates neutrophil phenotypes through the keratinocyte-derived CXCL-CXCR2 ligand-receptor axis. These findings uncover a microenvironmental mechanism governing neutrophil reprogramming and provide new insights into immune-parenchymal ligand-receptor communication in psoriasis.

Indexed as

KeratinocytesMediator Complex Subunit 1NeutrophilsPsoriasisReceptors, Interleukin-8BAnimalsChemokine CXCL1Chemokine CXCL2Disease Models, AnimalImiquimodMiceMice, KnockoutNeutrophil InfiltrationPhenotypeSignal TransductionChemokine CXCL1Chemokine CXCL2Cxcr2 protein, mouseImiquimodMed1 protein, mouseMediator Complex Subunit 1Receptors, Interleukin-8Bkeratinocytesligand-receptor axisneutrophilpsoriasisScRNA-seq

Identifiers

PMID42876837
PMCPMC13661492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.